Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-04

Clinical Trial Update: The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating PX0612 for irritable bowel syndrome with diarrhea; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PX0612

Snippet

Sponsor: Pharmabiotix Inc | Conditions: Irritable Bowel Syndrome With Diarrhea | NA | Status: COMPLETED | Results posted: 2019-10-04